Brochure | July 27, 2020

Moving Multiple Sclerosis Trials Forward, Faster

Source: Worldwide Clinical Trials

YOUR CRO PARTNER CAN HAVE A SIGNIFICANT IMPACT ON THE SUCCESS OR FAILURE OF YOUR CLINICAL STUDY AND PROGRAM.

As a full-service CRO, Worldwide Clinical Trials has an outstanding track record in starting up and executing MS studies, including beta-interferons, glatiramer acetate monoclonal antibodies, and oral preparations for disease-modifying approaches.

SPECIALIZATION IN MS PROGRAMS FOR ACCELERATED TRIALS

When timing is critical and everyday delays can cost millions, Worldwide’s simple, thorough, streamlined operations are critical to your neurology development program.

Whether your study is a small, focused single-region trial or a study that requires global reach, we designed our specialty MS team – neurologists; experienced clinical monitors and project managers; and regulatory, data management, statistical, scientific, and medical experts – to work collaboratively with you to help you overcome the high-risk, high-cost, time-intensive challenges of MS drug development.

VIEW THE BROCHURE!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader